{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:13:48Z","timestamp":1783545228700,"version":"3.55.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11_suppl_5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2004,12,14]]},"DOI":"10.1212\/wnl.63.11_suppl_5.s12","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:25:29Z","timestamp":1336919129000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":87,"title":["A multimodal approach to managing the symptoms of multiple sclerosis"],"prefix":"10.1212","volume":"63","author":[{"given":"Heidi","family":"Crayton","sequence":"first","affiliation":[{"name":"From the Georgetown University Multiple Sclerosis Center, Washington DC (Dr. Crayton); the Multiple Sclerosis Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr. Heyman); and the Multiple Sclerosis Center, Michigan Institute for Neurological Disorders, Farmington Hills, Michigan (Dr. Rossman)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rock A.","family":"Heyman","sequence":"additional","affiliation":[{"name":"From the Georgetown University Multiple Sclerosis Center, Washington DC (Dr. Crayton); the Multiple Sclerosis Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr. Heyman); and the Multiple Sclerosis Center, Michigan Institute for Neurological Disorders, Farmington Hills, Michigan (Dr. Rossman)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard S.","family":"Rossman","sequence":"additional","affiliation":[{"name":"From the Georgetown University Multiple Sclerosis Center, Washington DC (Dr. Crayton); the Multiple Sclerosis Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr. Heyman); and the Multiple Sclerosis Center, Michigan Institute for Neurological Disorders, Farmington Hills, Michigan (Dr. Rossman)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"120","volume":"5","year":"1999","unstructured":"Miller A, Bourdette D, Cohen JA, et al. Multiple sclerosis. Continuum. 1999; 5: 120\u2013133.","journal-title":"Continuum"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9993(94)90009-4"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.8_suppl_4.S32"},{"key":"e_1_3_2_5_2","unstructured":"Krupp  LB.  Mechanisms measurement and management of fatigue in multiple sclerosis. In:  Thompson AJ Polman C Hohfeld R eds.  Multiple sclerosis: clinical challenges and controversies.  London:  Martin Dunitz 1997:  283\u2013294."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050508"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02230913"},{"key":"e_1_3_2_8_2","first-page":"26","volume":"13","year":"1991","unstructured":"Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axon. 1991; 13: 26\u201328.","journal-title":"Axon"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199506000-00010"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1987.00520160018007"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(83)90414-6"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00887825"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91087-M"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720100070"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458502ms795rr"},{"key":"e_1_3_2_16_2","unstructured":"MS Society Symptom Management Survey. National Multiple Sclerosis Society 1997."},{"key":"e_1_3_2_17_2","unstructured":"Matthews  B.  Symptoms and signs of multiple sclerosis. In:  Compston A Ebers GC Lassman H et al. eds.  McAlpine\u2019s multiple sclerosis.  3rd ed.  London:  Churchill Livingstone 1998:  145\u2013190."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199406000-00009"},{"key":"e_1_3_2_19_2","first-page":"247","volume":"49","year":"2003","unstructured":"Rode G, Maupas E, Luaute J, Courtois-Jacquin S, Boisson D. Medical treatment of spasticity. Neurochirurgie. 2003; 49 (2\u20133 pt 2): 247\u2013255.","journal-title":"Neurochirurgie"},{"key":"e_1_3_2_20_2","first-page":"186","volume":"72","year":"1991","unstructured":"Brar SP, Smith MB, Nelson LM, Franklin GM, Cobble ND. Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis. Arch Phys Med Rehabil. 1991; 72: 186\u2013189.","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_2_21_2","first-page":"1","volume":"2","year":"2000","unstructured":"Kassirer M. Multiple sclerosis and pain. A medical focus. Int J MS Care [Serial online]. Oct 2000; 2: 1\u20138.","journal-title":"Int J MS Care [Serial online]"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550180049011"},{"key":"e_1_3_2_23_2","unstructured":"Lioresal\u00ae (baclofen) package insert. Novartis Pharmaceuticals Corp 2002."},{"key":"e_1_3_2_24_2","unstructured":"Zanaflex\u00ae package insert. Elan Pharmaceuticals Inc. Dublin Ireland 1996."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.23.12.1313"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1975.03260100016004"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.39.4.350"},{"key":"e_1_3_2_28_2","unstructured":"Joy  JE Johnston  RB.  Multiple sclerosis: current status and strategies for the future.  Washington DC:  National Academy Press 2001."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.78.2.0226"},{"key":"e_1_3_2_30_2","first-page":"127","volume":"4","year":"1991","unstructured":"Edgely K, Sullivan M, Dehoux E. A survey of multiple sclerosis: part 2. Determinants of employment status. Can J Rehab. 1991; 4: 127\u2013132.","journal-title":"Can J Rehab"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.2.179"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0765-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.8.1468"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245850100700602"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.5.967"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.11.1140"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Taus  C Solari  A D\u2019Amico  R et al.  Amantadine for fatigue in multiple sclerosis (Cochrane Review). In:  The Cochrane Library. Issue 4.  Chichester UK:  John Wiley & Sons 2003.","DOI":"10.1002\/14651858.CD002818"},{"key":"e_1_3_2_38_2","unstructured":"Schapiro R. Pharmacologic management of MS-related fatigue. Int J MS Care [Serial online]. October 2002supplement."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.5.685"},{"key":"e_1_3_2_40_2","first-page":"692","year":"1991","unstructured":"Rao SM, Leo GJ, Ellington L, et al. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 1991: 692\u2013696.","journal-title":"Neurology"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216070-00002"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.10.1602"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1463"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200006000-00010"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1037\/0894-4105.13.4.546"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025547431847"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(87)90052-1"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.3.628"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.140.11.1498"},{"key":"e_1_3_2_51_2","unstructured":"Avonex\u00ae (Interferon beta-1a) package insert.  Biogen Inc. Cambridge MA 2003."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/109.4.585"},{"key":"e_1_3_2_53_2","unstructured":"Betaseron\u00ae (Interferon beta-1b) package insert.  Berlex Laboratories Montville NJ 2002."},{"key":"e_1_3_2_54_2","unstructured":"Rebif\u00ae (Interferon beta-1a) package insert.  Serono Inc. Rockland MA;  2002."},{"key":"e_1_3_2_55_2","first-page":"1731","volume":"261","year":"1989","unstructured":"Wolkowitz OM, Rapaport M. Long-lasting behavioral changes following prednisone withdrawal. JAMA. 1989; 261: 1731\u20131732.","journal-title":"JAMA"},{"key":"e_1_3_2_56_2","unstructured":"Foster HE. Bladder symptoms and multiple sclerosis. MSQR. 2002; 21: Spring."},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)61760-9"},{"key":"e_1_3_2_58_2","first-page":"189","volume":"274","year":"1985","unstructured":"Cazzulani P, Panzarasa R, De Stefani C, Graziani G. Mechanism of flavoxate antispasmodic activity comparative in vitro studies. Arch Int Pharmacodyn Ther. 1985; 274: 189\u2013200.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_2_59_2","first-page":"2.","volume":"4","year":"2002","unstructured":"O\u2019Leary ML, Smith CP, Erickson JR, Heyman RA, Chancellor MB. Botulinum toxin urethral sphincter injection to restore bladder emptying in a woman with multiple sclerosis. Int J MS Care [Serial online]. June 2002; 4: 2.","journal-title":"Int J MS Care [Serial online]"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363020-00003"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00900497"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02049987"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290311"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1991.tb04937.x"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.12.1830"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1294"},{"key":"e_1_3_2_67_2","unstructured":"Bonica JJ ed.  The management of pain.  2nd ed.  Baltimore:  Williams & Wilkins 1990."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.2.611"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1714"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.6.1097"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1159\/000008192"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1042-3680(18)30337-1"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040950"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207459509004888"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.45.4.308"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520410091029"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.43.4.296"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.2.609"},{"key":"e_1_3_2_79_2","first-page":"14","volume":"10","year":"2003","unstructured":"Solaro C, Lunardi GL, Mancardi GL. Pain and MS. Int MS J. 2003; 10: 14\u201319.","journal-title":"Int MS J"},{"key":"e_1_3_2_80_2","first-page":"2642","volume":"165","year":"2003","unstructured":"Jonsson A. Disseminated sclerosis and sexuality. Ugeskr Laeger. 2003; 165: 2642\u20132646.","journal-title":"Ugeskr Laeger"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.6.1303"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245859900500i609"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.50.8.1076"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2001.tb10992.x"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.63.11_suppl_5.S12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T11:20:01Z","timestamp":1711538401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.63.11_suppl_5.S12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,14]]},"references-count":83,"journal-issue":{"issue":"11_suppl_5","published-print":{"date-parts":[[2004,12,14]]}},"alternative-id":["10.1212\/WNL.63.11_suppl_5.S12"],"URL":"https:\/\/doi.org\/10.1212\/wnl.63.11_suppl_5.s12","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,14]]}}}